Immunological variation between inbred laboratory mouse strains: Points to consider in phenotyping genetically immunomodified mice

Veterinary Pathology

Volumn 49, Issue 1, 2012, Pages 32-43

  Sellers, R S ^a   Clifford, C B ^b   Treuting, P M ^c   Brayton, C ^d  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b CHARLES RIVER LABORATORIES   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

acquired immunity; GEM; genetic engineering; immunodeficiency; immunophenotype; inbred mice; innate immunity; pathogens; phenotype; scid

Indexed keywords

ANIMAL; ANIMAL MODEL; ARTICLE; CLASSIFICATION; FEMALE; GENETIC ENGINEERING; GENETIC POLYMORPHISM; GENETICS; HUMAN; IMMUNOLOGY; INBRED MOUSE STRAIN; MALE; MOUSE; MUTATION; PHENOTYPE; TRANSGENIC MOUSE;

ANIMALS; FEMALE; GENETIC ENGINEERING; HUMANS; MALE; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; MODELS, ANIMAL; MUTATION; PHENOTYPE; POLYMORPHISM, GENETIC;

MUS;

EID: 84855381793     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985811429314     Document Type: Article

References (185)

1. Agostini L,Martinon F,Burns K, et al.NALP3 forms an IL-1beta-processing inflammasome with increased activity in muckle-wells autoinflammatory disorder.Immunity. 2004;20:319-325.
2. Arslan F,Keogh B,McGuirk P, et al.TLR2 and TLR4 in ischemia reperfusion injury.Mediators Inflamm. 2010;:.
3. Ashman RB.Candida albicans: pathogenesis, immunity and host defense.Res Immunol. 1998;149:281-288.
4. Ashman RB.A gene (Carg1) that regulates tissue resistance to Candida albicans maps to chromosome 14 of the mouse.Microb Pathog. 1998;25:333-335.
5. Bahring R,Milligan CJ,Vardanyan V, et al.Coupling of voltage-dependent potassium channel inactivation and oxidoreductase active site of Kvbeta subunits.J Biol Chem. 2001;276:22923-22929.
6. Beckwith J,Cong Y,Sundberg JP, et al.Cdcs1, a major colitogenic locus in mice, regulates innate and adaptive immune response to enteric bacterial antigens.Gastroenterology. 2005;129:1473-1484.
7. Behlke MA,Chou HS,Huppi K, et al.Murine T-cell receptor mutants with deletions of beta-chain variable region genes.Proc Natl Acad Sci U S A. 1986;83:767-771.
8. Behlke MA,Loh DY.Alternative splicing of murine T-cell receptor beta-chain transcripts.Nature. 1986;322:379-382.
9. Bennett K,Levine T,Ellis JS, et al.Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E.Eur J Immunol. 1992;22:1519-1524.
10. Berger SB,Romero X,Ma C, et al.SLAM is a microbial sensor that regulates bacterial phagosome functions in macrophages.Nat Immunol. 2010;11:920-927.
11. Bettelli E,Carrier Y,Gao W, et al.Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.Nature. 2006;441:235-238.
12. Bleich A,Büchler G,Beckwith J, et al.Cdcs1 a major colitis susceptibility locus in mice; Subcongenic analysis reveals genetic complexity.Inflamm Bowel Dis. 2010;16:765-775.
13. Boehm T.Design principles of adaptive immune systems.Nat Rev Immunol. 2011;11:307-317.
14. Bradley DJ.Letter: Genetic control of natural resistance to Leishmania donovani.Nature. 1974;250:353-354.
15. Brown J,Wang H,Hajishengallis GN, et al.TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk.J Dent Res. 2011;90:417-427.
16. Brown MG,Dokun AO,Heusel JW, et al.Vital involvement of a natural killer cell activation receptor in resistance to viral infection.Science. 2001;292:934-937.
17. Calpe S,Wang N,Romero X, et al.The SLAM and SAP gene families control innate and adaptive immune responses.Adv Immunol. 2008;97:177-250.
18. Carissimi C,Fulci V,Macino G.MicroRNAs: Novel regulators of immunity.Autoimmun Rev. 2009;8:520-524.
19. Caron J,Loredo-Osti JC,Laroche L, et al.Identification of genetic loci controlling bacterial clearance in experimental Salmonella enteritidis infection: an unexpected role of Nramp1 (Slc11a1) in the persistence of infection in mice.Genes Immun. 2002;3:196-204.
20. Carrier Y,Yuan J,Kuchroo VK, et al.Th3 cells in peripheral tolerance, I: induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice.J Immunol. 2007;178:179-185.
21. Chen CZ,Li L,Lodish HF, et al.MicroRNAs modulate hematopoietic lineage differentiation.Science. 2004;303:83-86.
22. Chen J,Flurkey K,Harrison DE.A reduced peripheral blood CD4(+) lymphocyte proportion is a consistent ageing phenotype.Mech Ageing Dev. 2002;123:145-153.
23. Chen J,Harrison DE.Quantitative trait loci regulating relative lymphocyte proportions in mouse peripheral blood.Blood. 2002;99:561-566.
24. Chen M,Daha MR,Kallenberg CGM.The complement system in systemic autoimmune disease.J Autoimmun. 2009;34:J276-J286.
25. Clemens MJ,Vaquero CM.Inhibition of protein synthesis by double-stranded RNA in reticulocyte lysates: evidence for activation of an endoribonuclease.Biochem Biophys Res Commun. 1978;83:59-68.
26. Cohen NR,Garg S,Brenner MB.Antigen presentation by CD1 lipids, T cells, and NKT cells in microbial immunity.Adv Immunol. 2009;102:1-94.
27. Cohen NR,Garg S,Brenner MB, et al.Antigen presentation by CD1: lipids, T cells, and NKT cells in microbial immunity.Adv Immunol. 2009;102:1-94.
28. Cook M,Caswell RC,Richards RJ, et al.Regulation of human and mouse procathepsin E gene expression.Eur J Biochem. 2001;268:2658-2668.
29. Corbett AJ,Coudert JD,Forbes CA, et al.Functional consequences of natural sequence variation of murine cytomegalovirus m157 for ly49 receptor specificity and NK cell activation.J Immunol. 2011;186:1713-1722.
30. Dai Y,Huang YS,Tang M, et al.Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients.Lupus. 2007;16:939-946.
31. Daniels KA,Devora G,Lai WC, et al.Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H.J Exp Med. 2001;194:29-44.
32. del Rio R,Sun Y,Alard P, et al.H2 control of natural T regulatory cell frequency in the lymph node correlates with susceptibility to day 3 thymectomy-induced autoimmune disease.J Immunol. 2011;186:382-389.
33. Demant P,Ivanyi D,Oudshoorn-Snoek M.Genetic complexity of H-2 antigens.Transplant Proc. 1981;13:1755-1758.
34. Demant P,Ivanyi D,Oudshoorn-Snoek M, et al.Molecular heterogeneity of H-2 antigens.Immunol Rev. 1981;60:5-22.
35. Denny P,Hopes E,Gingles N, et al.A major locus conferring susceptibility to infection by Streptococcus pneumoniae in mice.Mamm Genome. 2003;14:448-453.
36. Desrosiers MP,Kielczewska A,Loredo-Osti JC, et al.Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection.Nat Genet. 2005;37:593-599.
37. Dokun AO,Chu DT,Yang L, et al.Analysis of in situ NK cell responses during viral infection.J Immunol. 2001;167:5286-5293.
38. Dokun AO,Kim S,Smith HR, et al.Specific and nonspecific NK cell activation during virus infection.Nat Immunol. 2001;2:951-956.
39. Elkins KL,Cooper A,Colombini SM, et al.In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12 p70.Infect Immun. 2002;70:1936-1948.
40. Emoto M,Zerrahn J,Miyamoto M, et al.Phenotypic characterization of CD8+NKT cells.Eur. J. Immunol. 2000;30:2300-2311.
41. Fischer Lindahl K.On naming H2 haplotypes: functional significance of MHC class Ib alleles.Immunogenetics. 1997;46:53-62.
42. Forman J,Lindahl KFCurr Protoc Immunol. 2002:.
43. Fortier A,Min-Oo G,Forbes J, et al.Single gene effects in mouse models of host: pathogen interactions.J Leukocyte Biol. 2005;77:868-877.
44. Fox JG,Ge Z,Whary MT, et al.Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer.Mucosal Immunol. 2011;4:22-30.
45. Fox JG,Yan L,Shames B, et al.Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus.Infect Immun. 1996;64:3673-3681.
46. Garg S,Sharma M,Ung C, et al.Lysosomal trafficking, antigen presentation, and microbial killing are controlled by the Arf-like GTPase Arl8b.Immunity. 2011;35:182-193.
47. Geijtenbeek TB,Gringhuis SI.Signalling through C-type lectin receptors: shaping immune responses.Nat Rev Immunol. 2009;9:465-479.
48. Glineur S,Antoine-Moussiaux N,Michaux C, et al.Immune depression of the SJL/J mouse, a radioresistant and immunologically atypical inbred strain.Immunobiology. 2011;216:213-217.
49. Gombert JM,Herbelin A,Tancrede-Bohin E, et al.Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse.Eur J Immunol. 1996;26:2989-2998.
50. Gombert JM,Herbelin A,Tancrede-Bohin E, et al.Early defect of immunoregulatory T cells in autoimmune diabetes.C R Acad Sci III. 1996;319:125-129.
51. Guenet JL.Assessing the genetic component of the susceptibility of mice to viral infections.Brief Funct Genomic Proteomic. 2005;4:225-240.
52. Gutcher I,Becher B.APC-derived cytokines and T cell polarization in autoimmune inflammation.J Clin Invest. 2007;117:1119-1127.
53. Haller O,Stertz S,Kochs G.The Mx GTPase family of interferon-induced antiviral proteins.Microbes Infect. 2007;9:1636-1643.
54. Hannestad K,Scott H.The MHC haplotype H2b converts two pure nonlupus mouse strains to producers of antinuclear antibodies.J Immunol. 2009;183:3542-3550.
55. Harrington LE,Hatton RD,Mangan PR, et al.Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.Nat Immunol. 2005;6:1123-1132.
56. Harvill ET,Lee G,Grippe VK, et al.Complement depletion renders C57BL/6 mice sensitive to the bacillus anthracis sterne strain.Infect Immun. 2005;73:4420-4422.
57. Hasan U,Chaffois C,Gaillard C, et al.Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88.J Immunol. 2005;174:2942-2950.
58. Hebb A,Moore C,Bhan V, et al.Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination.Mult Scler. 2008;14:577-594.
59. Hogarth MB,Slingsby JH,Allen PJ, et al.Multiple lupus susceptibility loci map to chromosome 1 in BXSB mice.J Immunol. 1998;161:2753-2761.
60. Holers VM,Thurman JM.The alternative pathway of complement in disease: opportunities for therapeutic targeting.Mol Immunol. 2004;41:147-152.
61. Holling TM,Schooten E,van Den Elsen PJ.Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men.Hum Immunol. 2004;65:282-290.
62. Horak I,Lohler J,Ma A, et al.Interleukin-2 deficient mice: a new model to study autoimmunity and self-tolerance.Immunol Rev. 1995;148:35-44.
63. Huugen D,van Esch A,Xiao H, et al.Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice.Kidney Int. 2007;71:646-654.
64. Iwamura C,Nakayama T.Role of NKT cells in allergic asthma.Curr Opin Immunol. 2010;22:807-813.
65. Jeannin P,Jaillon S,Delneste Y.Pattern recognition receptors in the immune response against dying cells.Curr Opin Immunol. 2008;20:530-537.
66. Jeru I,Duquesnoy P,Fernandes-Alnemri T, et al.Mutations in NALP12 cause hereditary periodic fever syndromes.Proc Natl Acad Sci U S A. 2008;105:1614-1619.
67. Jiang W,Tang W,Geng Q, et al.Inhibition of Toll-like receptor 4 with vasoactive intestinal peptide attenuates liver ischemia-reperfusion injury.Transplant Proc. 2011;43:1462-1467.
68. Jin HK,Takada A,Kon Y, et al.Identification of the murine Mx2 gene: interferon-induced expression of the Mx2 protein from the feral mouse gene confers resistance to vesicular stomatitis virus.J Virol. 1999;73:4925-4930.
69. Jin HK,Yamashita T,Ochiai K, et al.Characterization and expression of the Mx1 gene in wild mouse species.Biochem Genet. 1998;36:311-322.
70. Jin HK,Yoshimatsu K,Takada A, et al.Mouse Mx2 protein inhibits hantavirus but not influenza virus replication.Arch Virol. 2001;146:41-49.
71. Jin Y-H,Kang HS,Mohindru M, et al.Preferential induction of protective T cell responses to Theiler's virus in resistant (C57BL/6 x SJL)F1 Mmice.J Virol. 2011;85:3033-3040.
72. Johnnidis JB,Harris MH,Wheeler RT, et al.Regulation of progenitor cell proliferation and granulocyte function by microRNA-223.Nature. 2008;451:1125-1129.
73. Kadioglu A,Andrew PW.Susceptibility and resistance to pneumococcal disease in mice.Brief Funct Genomic Proteomic. 2005;4:241-247.
74. Karamitros D,Kotantaki P,Lygerou Z, et al.T cell proliferation and homeostasis: an emerging role for the cell cycle inhibitor geminin.Crit Rev Immunol. 2011;31:209-231.
75. Kaufman JF,Auffray C,Korman AJ, et al.The class II molecules of the human and murine major histocompatibility complex.Cell. 1984;36:1-13.
76. Kelley VE,Roths JB.Interaction of mutant lpr gene with background strain influences renal disease.Clin Immunol Immunopathol. 1985;37:220-229.
77. Kennedy J,Vicari A,Saylor V, et al.A molecular analysis of NKT cells: identification of a class-I restricted T cell-associated molecule (CRTAM).J. Leukocyte Biol. 2000;67:725-734.
78. Keszei M,Latchman YE,Vanguri VK, et al.Auto-antibody production and glomerulonephritis in congenic Slamf1-/- and Slamf2-/- [B6.129] but not in Slamf1-/- and Slamf2-/- [BALB/c.129] mice.Int Immunol. 2011;23:149-158.
79. Kielczewska A,Kim HS,Lanier LL, et al.Critical residues at the Ly49 natural killer receptor's homodimer interface determine functional recognition of m157, a mouse cytomegalovirus MHC class I-like protein.J Immunol. 2007;178:369-377.
80. Kofoed EM,Vance RE.Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity.Nature. 2011;477:592-595.
81. Koh AE,Njoroge SW,Feliu M, et al.The SLAM family member CD48 (Slamf2) protects lupus-prone mice from autoimmune nephritis.J Autoimmun. 2011;37:48-57.
82. Kojo S,Adachi Y,Keino H, et al.Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases.Arthritis Rheum. 2001;44:1127-1138.
83. Ku CL,Yang K,Bustamante J, et al.Inherited disorders of human Toll-like receptor signaling: immunological implications.Immunol Rev. 2005;203:10-20.
84. Kumar S,Tarleton RL.Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice.J Immunol. 2001;166:4596-4603.
85. Kushwah R,Hu J.Complexity of dendritic cell subsets and their function in the host immune system.Immunology. 2011;133:409-419.
86. Kushwah R,Hu J.Role of dendritic cells in the induction of regulatory T cells.Cell Biosci. 2011;1:20.
87. Lamkanfi M,Dixit VM.Modulation of inflammasome pathways by bacterial and viral pathogens.J Immunol. 2011;187:597-602.
88. Lee H-H,Meyer EH,Goya S, et al.Apoptotic cells activate NKT cells through T cell Ig-like mucin-like-1 resulting in airway hyperreactivity.J Immunol. 2010;185:5225-5235.
89. Leng R-X,Pan H-F,Qin W-Z, et al.Role of microRNA-155 in autoimmunity.Cytokine Growth Factor Rev. 2011;22:141-147.
90. Lewis MJ,Botto M.Complement deficiencies in humans and animals: links to autoimmunity.Autoimmunity. 2006;39:367-378.
91. Li QJ,Chau J.Ebert PJ,et al.miR-181a is an intrinsic modulator of T cell sensitivity and selection.Cell. 2007;129:147-161.
92. Lindahl KF,Byers DE,Dabhi VM, et al.H2-M3, a full-service class Ib histocompatibility antigen.Annu Rev Immunol. 1997;15:851-879.
93. Lotzova E,Savary CA.Possible involvement of natural killer cells in bone marrow graft rejection.Biomedicine. 1977;27:341-344.
94. Mahler M,Leiter EH.Genetic and environmental context determines the course of colitis developing in IL-10-deficient mice.Inflamm Bowel Dis. 2002;8:347-355.
95. Makrigiannis AP,Anderson SK.The murine Ly49 family: form and function.Arch Immunol Ther Exp (Warsz). 2001;49:47-50.
96. Makrigiannis AP,Pau AT,Saleh A, et al.Class I MHC-binding characteristics of the 129/J Ly49 repertoire.J Immunol. 2001;166:5034-5043.
97. Martinez FO.Regulators of macrophage activation.Eur J Immunol. 41:1531-1534.
98. Massilamany C,Gangaplara A,Chapman N, et al.Detection of cardiac myosin heavy chain-alpha-specific CD4 cells by using MHC class II/IAk tetramers in A/J mice.J. Immunol. Methods. 2011;372:107-118.
99. Mattner F,Magram J,Ferrante J, et al.Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.Eur J Immunol. 1996;26:1553-1559.
100. Mayer A,Lilly F,Duran-Reynals ML.Genetically dominant resistance in mice to 3-methylcholanthrene-induced lymphoma.Proc Natl Acad Sci U S A. 1980;77:2960-2963.
101. McDade JE,Shepard CC,Fraser DW, et al.Legionnaires' disease.N Engl J Med. 1977;297:1197-1203.
102. McVicar DW,Winkler-Pickett R,Taylor LS, et al.Aberrant DAP12 signaling in the 129 strain of mice: implications for the analysis of gene-targeted mice.J Immunol. 2002;169:1721-1728.
103. Medina E,North RJ.Evidence inconsistent with a role for the Bcg gene (Nramp1) in resistance of mice to infection with virulent Mycobacterium tuberculosis.J Exp Med. 1996;183:1045-1051.
104. Medina E,North RJ.Mice that carry the resistance allele of the Bcg gene (Bcgr) develop a superior capacity to stabilize bacille Calmette-Guerin (BCG) infection in their lungs and spleen over a protracted period in the absence of specific immunity.Clin Exp Immunol. 1996;104:44-47.
105. Medina E,North RJ.Genetically susceptible mice remain proportionally more susceptible to tuberculosis after vaccination.Immunology. 1999;96:16-21.
106. Medina E,Rogerson BJ,North RJ.The Nramp1 antimicrobial resistance gene segregates independently of resistance to virulent Mycobacterium tuberculosis.Immunology. 1996;88:479-481.
107. Mevorach D,Mascarenhas JO,Gershov D, et al.Complement-dependent clearance of apoptotic cells by human macrophages.J Exp Med. 1998;188:2313-2320.
108. Mills CD,Kincaid K,Alt JM, et al.M-1/M-2 macrophages and the Th1/Th2 paradigm.J Immunol. 2000;164:6166-6173.
109. Milner J,Fasth A,Etzioni A.Autoimmunity in severe combined immunodeficiency (SCID): lessons from patients and experimental models.J Clin Immunol. 2008;28:29-33.
110. Moayeri M,Crown D,Newman ZL, et al.Inflammasome sensor Nlrp1b-dependent resistance to anthrax is mediated by caspase-1, IL-1 signaling and neutrophil recruitment.PLoS Pathog. 2010;6:e1001222.
111. Moretto MM,Lawlor EM,Khan IA.Lack of interleukin-12 in p40-deficient mice leads to poor CD8+ T-cell immunity against Encephalitozoon cuniculi infection.Infect Immun. 2010;78:2505-2511.
112. Morgan BP,Marchbank KJ,Longhi MP, et al.Complement: central to innate immunity and bridging to adaptive responses.Immunology Letters. 2005;97:171-179.
113. Mullauer L,Gruber P,Sebinger D, et al.Mutations in apoptosis genes: a pathogenetic factor for human disease.Mutat Res Rev Mut Res. 2001;488:211-231.
114. Mullick A,Elias M,Picard S, et al.Dysregulated inflammatory response to Candida albicans in a C5-deficient mouse strain.Infect Immun. 2004;72:5868-5876.
115. Murata H,Kita Y,Sakamoto A, et al.Limited TCR repertoire of infiltrating T cells in the kidneys of Sjogren's syndrome patients with interstitial nephritis.J Immunol. 1995;155:4084-4089.
116. Naiki M,Yoshida SH,Ansari AA, et al.Activation of autoreactive T-cell clones from NZB.H-2bm12 mice.J Autoimmun. 1994;7:275-290.
117. Nakasa T,Miyaki S,Okubo A, et al.Expression of microRNA-146 in rheumatoid arthritis synovial tissue.Arthritis Rheum. 2008;58:1284-1292.
118. Netea Mihai G,Quintin J,Van der,Meer Jos WM.Trained immunity: a memory for innate host defense.Cell Host Microbe. 2011;9:355-361.
119. Newman ZL,Crown D,Leppla SH, et al.Anthrax lethal toxin activates the inflammasome in sensitive rat macrophages.Biochem Biophys Res Commun. 2010;398:785-789.
120. Noben-Trauth N,Kropf P,Muller I.Susceptibility to Leishmania major infection in interleukin-4-deficient mice.Science. 1996;271:987-990.
121. Nonoyama S,Smith FO,Bernstein ID, et al.Strain-dependent leakiness of mice with severe combined immune deficiency.J Immunol. 1993;150:3817-3824.
122. O'Brien AD,Rosenstreich DL,Scher I, et al.Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene.J Immunol. 1980;124:20-24.
123. O'Shea JJ,Paul WE.Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells.Science. 327:1098-1102.
124. Oliveira A-C,de Alencar BC,Tzelepis F, et al.Impaired innate immunity in Tlr4-/- mice but preserved CD8+ T cell responses against trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice.PLoS Pathog. 2010;6:e1000870.
125. Osman GE,Hannibal MC,Anderson JP, et al.T-cell receptor vbeta deletion and valpha polymorphism are responsible for the resistance of SWR mouse to arthritis induction.Immunogenetics. 1999;49:764-772.
126. Patel SN,Berghout J,Lovegrove FE, et al.C5 deficiency and C5a or C5aR blockade protects against cerebral malaria.J Exp Med. 2008;205:1133-1143.
127. Pavlovic J,Schroder A,Blank A, et al.Mx proteins: GTPases involved in the interferon-induced antiviral state.Ciba Found Symp. 1993;176:233-243.
128. Pepper M,Jenkins MK.Origins of CD4(+) effector and central memory T cells.Nat Immunol. 2011;12:467-471.
129. Pitossi F,Blank A,Schroder A, et al.A functional GTP-binding motif is necessary for antiviral activity of Mx proteins.J Virol. 1993;67:6726-6732.
130. Poltorak A,He X,Smirnova I, et al.Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.Science. 1998;282:2085-2088.
131. Prince LR,Whyte MK,Sabroe I, et al.The role of TLRs in neutrophil activation.Curr Opin Pharm. 2011;11:397-403.
132. Radovanovic I,Mullick A,Gros P.Genetic control of susceptibility to infection with Candida albicans in mice.PLoS One. 2011;6:e18957.
133. Ragin MJ,Sahu N,August A.Differential regulation of cytokine production by CD1d-restricted NKT cells in response to superantigen staphylococcal enterotoxin B exposure.Infect Immun. 2006;74:282-288.
134. Ripoll VM,Kadioglu A,Cox R, et al.Macrophages from BALB/c and CBA/Ca mice differ in their cellular responses to Streptococcus pneumoniae.J. Leukocyte Biol. 2010;87:735-741.
135. Sabbah A,Chang TH,Harnack R, et al.Activation of innate immune antiviral responses by Nod2.Nat Immunol. 2009;10:1073-1080.
136. Sadlack B,Lohler J,Schorle H, et al.Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells.Eur J Immunol. 1995;25:3053-3059.
137. Sadlack B,Löhler J,Schorle H, et al.Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells.Eur J Immunol. 1995;25:3053-3059.
138. Schatz DG,Ji Y.Recombination centres and the orchestration of V(D)J recombination.Nat Rev Immunol. 2011;11:251-263.
139. Shi Z,Cai Z,Sanchez A, et al.A novel toll-like receptor that recognizes vesicular stomatitis virus.J Biol Chem. 2011;286:4517-4524.
140. Shoham S,Huang C,Chen JM, et al.Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule.J Immunol. 2001;166:4620-4626.
141. Simpson EM,Linder CC,Sargent EE, et al.Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice.Nat Genet. 1997;16:19-27.
142. Skeldon A,Saleh M.The inflammasomes: molecular effectors of host resistance against bacterial, viral, parasitic, and fungal infections.Front Microbiol. 2011;2:15.
143. Smith GS,Walford RL,Mickey MR.Lifespan and incidence of cancer and other diseases in selected long-lived inbred mice and their F 1 hybrids.J Natl Cancer Inst. 1973;50:1195-1213.
144. Sorrentino R,Arditi M.Innate immunity, Toll-like receptors, and atherosclerosis: mouse models and methods.Methods Mol Biol. 2009;517:381-399.
145. Staeheli P,Pitossi F,Pavlovic J.Mx proteins: GTPases with antiviral activity.Trends Cell Biol. 1993;3:268-272.
146. Stark JM,McDowell SA,Koenigsknecht V, et al.Genetic susceptibility to respiratory syncytial virus infection in inbred mice.J Med Virol. 2002;67:92-100.
147. Stober CB,Brode S,White JK, et al.Slc11a1, formerly Nramp1, is expressed in dendritic cells and influences major histocompatibility complex class II expression and antigen-presenting cell function.Infect Immun. 2007;75:5059-5067.
148. Stranden AM,Staeheli P,Pavlovic J.Function of the mouse Mx1 protein is inhibited by overexpression of the PB2 protein of influenza virus.Virology. 1993;197:642-651.
149. Strutt TM,McKinstry KK,Swain SL.Functionally diverse subsets in CD4 T cell responses against influenza.J Clin Immunol. 2009;29:145-150.
150. Suhs KA,Marthaler BR.Welch RA,et al.Lack of association between the Tlr4 (Lpsd/Lpsd) genotype and increased susceptibility to Escherichia coli bladder infections in female C3H/HeJ mice.mBio. 2011;2:e00094-11.
151. Sun K,Gan Y,Metzger DW.Analysis of murine genetic predisposition to pneumococcal infection reveals a critical role of alveolar macrophages in maintaining the sterility of the lower respiratory tract.Infect Immun. 2011;79:1842-1847.
152. Svirshchevskaya EV,Shevchenko MA,Huet D, et al.Susceptibility of mice to invasive aspergillosis correlates with delayed cell influx into the lungs.Int J Immunogenet. 2009;36:289-299.
153. Swihart K,Fruth U,Messmer N, et al.Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response.J Exp Med. 1995;181:961-971.
154. Sypek JP,Chung CL,Mayor SE, et al.Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response.J Exp Med. 1993;177:1797-1802.
155. Takeuchi O,Akira S.Pattern recognition receptors and inflammation.Cell. 2010;140:805-820.
156. Tefit JN,Davies G,Serra V.NKT cell responses to glycolipid activation.Methods Mol Biol. 2010;626:149-167.
157. Tregoning JS,Yamaguchi Y,Wang B, et al.Genetic susceptibility to the delayed sequelae of neonatal respiratory syncytial virus infection is MHC dependent.J Immunol. 2010;185:5384-5391.
158. Tsukuba T,Yanagawa M,Okamoto K, et al.Impaired chemotaxis and cell adhesion due to decrease in several cell-surface receptors in cathepsin E-deficient macrophages.J Biol Chem. 2009;145:565-573.
159. Tulone C,Tsang J,Prokopowicz Z, et al.Natural cathepsin E deficiency in the immune system of C57BL/6J mice.Immunogenetics. 2007;59:927-935.
160. Tupin E,Kinjo Y,Kronenberg M.The unique role of natural killer T cells in the response to microorganisms.Nat Rev Micro. 2007;5:405-417.
161. Upragarin N,Nishimura H,Wajjwalku W, et al.T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus.J Immunol. 1997;159:2189-2195.
162. Valdez Y,Grassl GA,Guttman JA, et al.Nramp1 drives an accelerated inflammatory response during Salmonella-induced colitis in mice.Cell Microbiol. 2009;11:351-362.
163. Veazey RS,Horohov DW,Krahenbuhl JL, et al.Comparison of the resistance of C57BL/6 and C3H/He mice to infection with Mycobacterium paratuberculosis.Veterinary Microbiology. 1995;47:79-87.
164. Vidal S,Tremblay ML,Govoni G, et al.The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene.J Exp Med. 1995;182:655-666.
165. Vidal SM,Malo D,Vogan K, et al.Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg.Cell. 1993;73:469-485.
166. Wandstrat AE,Nguyen C,Limaye N, et al.Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus.Immunity. 2004;21:769-780.
167. Wang X,Moser C,Louboutin JP, et al.Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung.J Immunol. 2002;168:810-815.
168. Wang Y,Abarbanell AM,Herrmann JL, et al.Toll-like receptor signaling pathways and the evidence linking toll-like receptor signaling to cardiac ischemia/reperfusion injury.Shock. 2010;34:548-557.
169. Wang Y,Kristan J,Hao L, et al.A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis.J Immunol. 2000;164:4340-4347.
170. Ward JM,Anver MR,Haines DC, et al.Inflammatory large bowel disease in immunodeficient mice naturally infected with Helicobacter hepaticus.Lab Anim Sci. 1996;46:15-20.
171. Watters TM,Kenny EF,O'Neill LA.Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins.Immunol Cell Biol. 2007;85:411-419.
172. Weiner HL,da Cunha AP,Quintana F,Wu H.Oral tolerance.Immunol Rev. 2011;241:241-259.
173. Wetsel RA,Fleischer DT,Haviland DL.Deficiency of the murine fifth complement component (C5): a 2-base pair gene deletion in a 5'-exon.J Biol Chem. 1990;265:2435-2440.
174. Wieland CW,van Lieshout MH,Hoogendijk AJ, et al.Host defence during Klebsiella pneumonia relies on haematopoietic-expressed Toll-like receptors 4 and 2.Eur Respir J. 2010;37:848-857.
175. Williams L,Bradley L,Smith A, et al.Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages.J Immunol. 2004;172:567-576.
176. Williams LM,Ricchetti G,Sarma U, et al.Interleukin-10 suppression of myeloid cell activation--a continuing puzzle.Immunology. 2004;113:281-292.
177. Witherden DA,Havran WL.Costimulating epithelial gammadelta T cells.Cell Cycle. 2010;10:4-5.
178. Witherden DA,Havran WL.Molecular aspects of epithelial gammadelta T cell regulation.Trends Immunol. 2011;32:265-271.
179. Woods JP,Frelinger JA,Warrack G, et al.Mouse genetic locus Lps influences susceptibility to Neisseria meningitidis infection.Infect Immun. 1988;56:1950-1955.
180. Yamamoto Y,Okubo S,Klein TW, et al.Binding of Legionella pneumophila to macrophages increases cellular cytokine mRNA.Infect Immun. 1994;62:3947-3956.
181. Yamasaki S,Ishikawa E,Sakuma M, et al.Mincle is an ITAM-coupled activating receptor that senses damaged cells.Nat Immunol. 2008;9:1179-1188.
182. Yee CS,Yao Y,Li P, et al.Cathepsin E: a novel target for regulation by class II transactivator.J Immunol. 2004;172:5528-5534.
183. Yoshimoto T,Bendelac A,Watson C, et al.Role of NK1.1+ T cells in a TH2 response and in immunoglobulin E production.Science. 1995;270:1845-1847.
184. Yung Yu C,Yang Z,Blanchong CA, et al.The human and mouse MHC class III region: a parade of 21 genes at the centromeric segment.Immunol Today. 2000;21:320-328.
185. Zaidi N,Hermann C,Herrmann T, et al.Emerging functional roles of cathepsin E.Biochem Biophys Res Commun. 2008;377:327-330.